Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | VDRM |
---|---|---|
09:32 ET | 100000 | 0.0082 |
09:33 ET | 140000 | 0.0086 |
09:35 ET | 43000 | 0.0086 |
09:39 ET | 25000 | 0.0089 |
09:42 ET | 50000 | 0.0092 |
09:55 ET | 23990 | 0.0099 |
10:00 ET | 59588 | 0.01 |
10:02 ET | 720000 | 0.01 |
10:13 ET | 10000 | 0.00945 |
10:15 ET | 25000 | 0.011 |
10:22 ET | 188 | 0.0099 |
10:24 ET | 2000 | 0.0094 |
10:33 ET | 4000 | 0.00935 |
10:44 ET | 6800 | 0.009 |
10:45 ET | 500000 | 0.009 |
10:47 ET | 40000 | 0.009 |
11:09 ET | 50000 | 0.009 |
11:20 ET | 25000 | 0.0091 |
11:23 ET | 850 | 0.00945 |
11:32 ET | 167843 | 0.0091 |
11:36 ET | 314213 | 0.0087 |
11:50 ET | 1003998 | 0.00815 |
11:52 ET | 11200 | 0.00895 |
11:56 ET | 1922 | 0.0083 |
11:57 ET | 4500 | 0.0089 |
11:59 ET | 590000 | 0.0088 |
12:03 ET | 5000 | 0.0095 |
12:06 ET | 12500 | 0.00889 |
12:17 ET | 5000 | 0.00885 |
12:19 ET | 7500 | 0.00879 |
12:21 ET | 7500 | 0.0083 |
12:24 ET | 10000 | 0.00874 |
12:26 ET | 10000 | 0.00875 |
12:28 ET | 10000 | 0.00874 |
12:30 ET | 12500 | 0.00875 |
12:32 ET | 6922 | 0.00875 |
12:33 ET | 100 | 0.0083 |
12:44 ET | 150 | 0.0083 |
01:06 ET | 30000 | 0.00865 |
01:49 ET | 70000 | 0.0086 |
01:54 ET | 20000 | 0.0089 |
02:03 ET | 20112 | 0.008775 |
02:38 ET | 1014611 | 0.0077 |
02:39 ET | 10000 | 0.0085 |
02:45 ET | 5000 | 0.0082 |
02:56 ET | 9000 | 0.0082 |
03:06 ET | 20000 | 0.00819 |
03:12 ET | 15000 | 0.0082 |
03:19 ET | 5750 | 0.0087 |
03:50 ET | 1739 | 0.0077 |
03:53 ET | 2500 | 0.0077 |
03:57 ET | 50000 | 0.0087 |
04:00 ET | 152173 | 0.0087 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Viaderma Inc | 10.7M | 0.0x | --- |
Turnstone Biologics Corp | 10.9M | -0.1x | --- |
Cara Therapeutics Inc | 17.0M | -0.2x | --- |
Gritstone bio Inc | 3.2M | 0.0x | --- |
HOOKIPA Pharma Inc | 27.7M | -0.6x | --- |
Response Genetics Inc | 40.0 | 0.0x | --- |
ViaDerma, Inc. is a specialty pharmaceutical company engaged in bringing new products to market and licensing its transdermal drug delivery technology solutions. The Company’s lead product is a topical antibiotic, which is focused on being sold under the brand name Vitastem. In addition to licensing its proprietary transdermal technologies, its lead product, Vitastem, is available for treating multiple skin conditions and ailments. The Company also has products in development in fields, such as anti-aging skin care, pain management, hair-loss, and toenail fungus. The products are based on a delivery system technology that allows for rapid mass transfer of the pharmaceutical active ingredient across the skin and into the body to provide immediate localized therapy. The Company’s products are sold to local medical practitioners and patients in clinics primarily in the Los Angeles, California area. The Company’s subsidiary is ViaDerma, II Inc.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $10.7M |
---|---|
Revenue (TTM) | $17.8M |
Shares Outstanding | 1.2B |
Viaderma Inc does not pay a dividend. | |
Beta | -0.42 |
EPS | $16.84 |
Book Value | $244.39 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 0.6 |
Price/Cash Flow (TTM) | 2.0x |
Operating Margin | 21.02% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.